Clinical Trial Update: Everolimus, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Untreated Diffuse Large B-Cell Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 trial update evaluating everolimus in combination with rituximab and chemotherapy for newly diagnosed untreated diffuse large B-cell lymphoma. The study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Everolimus (everolimus)
• Rituximab (rituximab)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Lymphoma | Phase 1 | Status: COMPLETED